Answers are grounded in this paper and cite their sources.
Shows early-life oral vaccination enhances intestinal immunity in mice, suggesting potential for protection against rotavirus infection.
Resident memory T cells (Trm) are key mediators of protective immunity at barrier sites, yet their development during early life remains poorly defined. Here, we show that early-life oral vaccination with a heterologous rhesus rotavirus (RV) induces short-lived intestinal Trm that are negative by intravascular staining and express a CD44+CD69+CD103+/-P2X7R+ phenotype. Blocking lymphocyte homing with an anti-α4β7 antibody during vaccination did not alter the magnitude of RV-specific intestinal T cells or affect protection following murine RV challenge. In contrast, reduction of RV-specific intraepithelial lymphocytes by nicotinamide adenine dinucleotide treatment, or genetic deletion of the aryl hydrocarbon receptor repressor (Ahrr-/- mice)-which also exhibit decreased intraepithelial CD8+ T cells after infection-resulted in increased viral antigen shedding upon challenge. These results suggest that intestinal Trm cells induced by early-life vaccination may contribute to protection against RV infection.
No takes yet. Share an insight, caveat, or question.
Montenegro et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: